What is the Varicose Veins Treatment Market Size in 2026?

The global varicose veins treatment market size was valued at USD 1.59 billion in 2025 and is projected to grow from USD 1.69 billion in 2026 to approximately USD 2.96 billion by 2035, expanding at a CAGR of 6.44% from 2026 to 2035. The market is gaining momentum due to the rising incidence of venous disorders and the growing preference for minimally invasive treatment options.

Read Also: Tissue Nanotransfection Market

Market Overview

Varicose veins are a common manifestation of chronic venous insufficiency, particularly affecting the aging population and individuals with sedentary lifestyles. The increasing availability of advanced, minimally invasive procedures such as:

• Injection sclerotherapy

• Laser ablation

• Radiofrequency ablation

has significantly improved patient outcomes while reducing recovery time and procedural discomfort.

Growing healthcare awareness, improved diagnostic tools, expanding insurance coverage, and better outpatient infrastructure are collectively driving steady global market expansion.

Key Takeaways

• North America dominated the market in 2025.

• Asia Pacific is expected to grow at the fastest CAGR between 2026 and 2035.

• By type, injection sclerotherapy held the largest share in 2025.

• Endovenous ablation is projected to expand at the fastest CAGR.

• By end-use, hospitals led the market in 2025.

• Ambulatory surgical centers (ASCs) are expected to grow at a strong CAGR over the forecast period.

Why is the Varicose Veins Treatment Market Gaining Momentum?

The market is expanding steadily due to:

• Rising prevalence of chronic venous diseases

• Increasing aging population

• Sedentary lifestyle trends

• Growing cosmetic consciousness

• Higher preference for minimally invasive procedures

Outpatient-based procedures are improving operational efficiency for healthcare providers while reducing overall costs. Continuous advancements in catheter-based systems and imaging technologies are further enabling faster recovery and improved patient satisfaction.

How is Artificial Intelligence Transforming the Market?

Artificial Intelligence (AI) is enhancing diagnostic accuracy and treatment planning in the varicose veins treatment landscape.

AI-enabled technologies help:

• Analyze vein structure and disease severity

• Support the selection of optimal minimally invasive procedures

• Identify high-risk patients using predictive analytics

• Improve clinical outcomes through data-driven insights

As healthcare systems adopt intelligent platforms, AI integration is opening new opportunities for precision vein care.

Major Market Trends

1. Growing Adoption of Minimally Invasive Procedures

Laser ablation, radiofrequency ablation, and sclerotherapy are preferred due to reduced pain and shorter recovery time.

2. Rising Cosmetic Awareness

Patients are increasingly seeking treatment not only for medical reasons but also for aesthetic improvement.

3. Technological Advancements

Advanced imaging and catheter-based systems are enhancing procedural precision and safety.

4. Shift Toward Outpatient Settings

Ambulatory surgical centers are gaining popularity due to cost efficiency and faster discharge times.

5. Aging Population Growth

Older individuals are more susceptible to venous insufficiency, sustaining long-term demand.

6. Sedentary Lifestyle Impact

Prolonged sitting and reduced physical activity contribute to higher disease prevalence.

Future Market Outlook

The future of the varicose veins treatment market is shaped by:

• Expansion in emerging economies

• Development of non-thermal technologies

• Product innovation for enhanced patient comfort

• Growth of specialty vein clinics

• Integration with digital health and telemedicine platforms

• Rising medical tourism

• Preventive care initiatives

Market Scope

Segment Insights

Type Insights

Why Did Injection Sclerotherapy Dominate in 2025?

Injection sclerotherapy held the largest market share in 2025 due to:

• Affordability

• Suitability for small-to-medium veins

• Minimally invasive nature

• Quick recovery

• Strong patient preference for non-surgical treatments

The procedure is commonly performed in outpatient settings, strengthening its market dominance.

Endovenous Ablation: Fastest Growing Segment

Endovenous ablation is projected to grow at the fastest CAGR due to:

• Long-term treatment efficacy

• High success rates

• Advanced laser and radiofrequency technologies

• Image-guided precision techniques

• Growing physician and patient awareness

End-Use Insights

Why Did Hospitals Lead the Market?

Hospitals dominated in 2025 due to:

• Availability of vascular specialists

• Advanced treatment infrastructure

• Comprehensive diagnostic capabilities

• Insurance reimbursement support

• Ability to manage complex venous cases

Ambulatory Surgical Centers (ASCs): Rapid Growth Ahead

ASCs are expected to grow rapidly because of:

• Lower treatment costs

• Shorter waiting times

• Faster discharge

• Improved reimbursement support

• Streamlined operational efficiency

Regional Insights

North America: Market Leader

North America held the largest share in 2025 due to:

• Strong healthcare infrastructure

• Early adoption of advanced technologies

• High awareness levels

• Favorable reimbursement policies

• Large aging population

U.S. Market Trends

The U.S. market continues to expand due to:

• Growing demand for minimally invasive procedures

• Increased aesthetic awareness

• Strong presence of major device manufacturers

• Expansion of outpatient treatments

• Insurance coverage growth

Asia Pacific: Fastest Growing Region

Asia Pacific is projected to grow at the fastest CAGR because of:

• Expanding healthcare infrastructure

• Rising disposable income

• Growing patient awareness

• Increasing medical tourism

• Government support for vascular care programs

India Market Trends

India’s market is expanding due to:

• Rising lifestyle-related venous disorders

• Growing specialty clinics

• Improved affordability

• Medical tourism inflow

• Increasing awareness campaigns

Europe: Steady Expansion

Europe accounts for a substantial share and is expected to grow steadily due to:

• Well-developed healthcare systems

• Aging population

• Strong reimbursement frameworks

• Early adoption of minimally invasive procedures

Germany Market Trends

Germany is a key contributor owing to:

• Advanced medical facilities

• Favorable reimbursement policies

• High adoption of endovenous ablation

• Strong outpatient care networks

• Rising demand for cosmetic vein correction

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com